Chiesi Limited: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·Manchester·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPDRG-6355-YCVGCompanies House02140985 ↗ · Active
Where they wini
i
54 awards (54 for a named lot, 100%, 0 for a whole procedure with no lot named) · top CPV classes, shares of all 54 awards. An award may cover more than one class.
3360 Pharmaceutical products54 awards · 100% · awards naming a loti
i
Largest published awards i | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Proprietary Drugs | eTenderwales | — | — | £6,368,400 † |
| Revcovi infusion | Southern Health and Social Care Trust | 3 Sept 2025 | 3 yrs | £3,996,000 ≈ £1.3m/yr |
| (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial | Belfast Health & Social Care Trust | 21 May 2025 | 2 yrs | £2,600,000 ≈ £1.3m/yr |
| Proprietary Drugs | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £932,284 † |
| Generic Drugs - Topicals/Miscellaneous | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £379,944 † |
Where their buyers arei
i
ITL1 region of the buyer office · known for 39 of 39 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 3 notices name this supplier since 22 Dec 2025 · observed bids, not an estimate
i
i
i
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointed | 125 | 9 Oct 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointed | 118 | 26 Feb 2026 |
| NHS National Framework for Generics Housekeeping | NHS England | appointed | 53 | 22 Dec 2025 |
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health83%(45 awards)
45 of 54 awards are NHS & health (83%).Type not classified17%(9 awards)
9 of 54 awards are Type not classified (17%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 14 | 35.9% | 18 | 27 Aug 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 11 | 28.2% | 17 | 9 Apr 2026 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 7 | 17.9% | 7 | 13 Jun 2025 |
| Business Services Organisation Procurement and Logistics Service | 3 | 7.7% | 8 | 5 Jan 2026 |
| eTenderwales | 1 | 2.6% | 1 | 17 Jun 2025 |
| Southern Health and Social Care Trust | 1 | 2.6% | 1 | 3 Sept 2025 |
| Belfast Health & Social Care Trust | 1 | 2.6% | 1 | 21 May 2025 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 | 2.6% | 1 | 30 Nov 2021 |
Share = of the 39 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
51 of 54 awards carry an end date, 23 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £33,344 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 ceiling |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 ceiling |
| NHS National Framework for Generics Housekeeping Lot 1 - Oral Products | 31 May 2027 | £17,843,324 ceiling |
| Medicinal Products - Direct to Trust | 2 Jun 2027 estimated | £210,000,000 ceiling |
| (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial | 30 Jun 2027 | £2,600,000 |
| Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | 31 Jul 2027 | £3,594,493 ceiling |
| Wave 15b - Hospital Only DCE & DSW regions | 30 Sept 2027 | £1 ceiling |
| Lot 16 - Tramadol Hydrochloride Modified Release Tablets | 2 Dec 2027 estimated | £10,521 ceiling |
| Lot 21 - All other Analgesics and Anaesthetic Generic Medicines | 2 Dec 2027 estimated | £15,957,588 ceiling |
Soonest 10 of 13.
Recent awards
Latest 30 of 54 award records naming this supplier
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 28 of 54 awards, estimated from the published duration on 23 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.